Manuelle Touzard

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study

Adrian Newman‐Tancredi, Samantha Gavaudan, Caroline Conte et al. · European Journal of Pharmacology · 1998 · 226 citations

Medicine, Pharmacology, Psychiatry +13

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

Adrian Newman‐Tancredi, Didier Cussac, Yann Quentric et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 194 citations

Medicine, Pharmacology, Pharmacotherapy +17

Actions of α2 adrenoceptor ligands at α2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for α2A adrenoceptors

Adrian Newman‐Tancredi, Jean‐Paul Nicolas, Valérie Audinot et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1998 · 119 citations

Medicine, Pharmacology, Molecular Pharmacology +11

Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agents

Mauricette Brocco, Anne Dekeyne, Clotilde Mannoury la Cour et al. · European Neuropsychopharmacology · 2008 · 30 citations

Medicine, Neuroscience, Pharmacology +10

Comparison of hippocampal G protein activation by 5-HT 1A receptor agonists and the atypical antipsychotics clozapine and S16924

Adrian Newman‐Tancredi, Jean‐Michel Rivet, Didier Cussac et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2003 · 29 citations

Life Sciences, Neuroscience, Pharmacology +16